A Prospective Study of Hypertension and Arrhythmias in CLL Patients Treated With Bruton ' s Tyrosine Kinase Inhibitors
Conditions: Chronic Lymphocytic Leukemia; Atrial Fibrillation; Hypertension; Cardiotoxicity Interventions: Other: no intervention Sponsors: Abramson Cancer Center at Penn Medicine Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Arrhythmia | Atrial Fibrillation | Cancer | Cancer & Oncology | Cardiology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Heart | Hypertension | Leukemia | Research | Study